Articles related to Hematology/Oncology

Leukemia progression depends on where cells are affected in the maturation process, determining treatment urgency and functional capacity of abnormal blood cells.

Despite poor prognosis at treatment initiation, extended follow-up reveals sustained remissions suggesting curative potential in heavily pretreated CLL patients receiving CD19-directed cellular immunotherapy.

Nature exposure demonstrates measurable psychological benefits for cancer patients, including reduced anxiety and improved quality of life, though direct immune system claims require further clinical validation.

Reed-Sternberg cells harbor chromosome 9p24 amplification encoding PD-1 ligand, creating therapeutic vulnerability exploited by checkpoint inhibitors with remarkable clinical responses.

A section of the new report titled ‘Collapse of Cancer Care’ details how staffing shortages, inadequate resources, and poor management at HCA Mission Hospital led to a severe decline in oncology services.

The emergence of novel agents including BTK degraders, next-generation BCL2 inhibitors, and optimized combination approaches is reshaping the CLL treatment landscape, with multiple trials demonstrating high uMRD rates, improved progression-free survival, and manageable toxicity profiles across different patient populations.